Richard H. Scheller, See Remarks at BridgeBio Pharma, Inc. (BBIO), sold 60,000 shares at $64.99 ($3.9M) on 2020-12-18, disclosed to the SEC on 2020-12-21.
Open-market sale of $3.9M BBIO by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.99 | 27,105 | $1.8M | 45.1% |
| 2 | $64.99 | 27,105 | $1.8M | 45.1% |
| 3 | $65.78 | 2,895 | $190K | 4.9% |
| 4 | $65.78 | 2,895 | $190K | 4.9% |
| Total | $65.07 avg | 60,000 | $3.9M | 100% |
| Filing → |
| DICE | SELL | 2023-05-09 | $6.5M | — | Filing → |
| ME | SELL | 2022-11-14 | $119K | — | Filing → |
| ALEC | SELL | 2021-08-09 | $3.7M | — | Filing → |